Associations Between Alcohol Consumption Patterns and Dyslipidemia Among Chinese Adults Aged 18 and Above: China Nutrition and Health Surveillance (2015–2017)
Abstract
1. Introduction
2. Data Sources and Methods
2.1. Study Design
2.2. Data Collection
2.3. Diagnosis of Dyslipidemia
- (1)
- Serum total cholesterol level (TC) ≥ 6.2 mmol/L was diagnosed as hypercholesterolemia;
- (2)
- Serum triglyceride level (TG) ≥ 2.3 mmol/L was diagnosed as hypertriglyceridemia;
- (3)
- High-density lipoprotein cholesterol level (HDL-C) < 1.0 mmol/L was diagnosed as low HDL-C;
- (4)
- Serum low-density lipoprotein cholesterol level (LDL-C) ≥ 4.1 mmol/L was diagnosed as high LDL-C.
2.4. Assessment of Alcohol Intake and Grouping
2.5. Variables of Influencing Factors
2.6. Statistical Analysis
3. Results
3.1. Characteristics of Research Subjects
3.2. Drinking Status of Chinese Residents
3.3. Blood Lipid Levels of Adult Residents with Different Drinking Behaviors
3.4. The Relationship Between Male Drinking Behavior and Different Types of Dyslipidemia
3.5. The Relationship Between Female Drinking Behavior and Different Types of Dyslipidemia
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- World Health Organization. Global Status Report on Alcohol and Health 2018; WHO: Geneva, Switzerland, 2018.
- Ference, B.A.; Ginsberg, H.N.; Graham, I.; Ray, K.K.; Packard, C.J.; Bruckert, E.; Hegele, R.A.; Krauss, R.M.; Rfaal, F.J.; Schunkert, H.; et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur. Heart J. 2017, 38, 2459–2472. [Google Scholar] [CrossRef]
- Laboratory Medicine Society of Chinese Medical Association; Branch of Laboratory Physicians of Chinese Medical Doctor Association; Lipids and Lipoproteins Committee; Cholesterol Treatment Trialists’ (CTT) Collaboration; Fulcher, J.; O’Connell, R.; Voysey, M.; Emberson, E.; Blackwell, L.; Mihaylova, B.; et al. Chinese Clinical Lipid Testing Guidelines. Chin. J. Lab. Med. 2022, 45, 1017–1033. [Google Scholar]
- Gotto, A.M., Jr.; Brinton, E.A. Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: A working group report and update. J. Am. Coll. Cardiol. 2004, 43, 717–724. [Google Scholar] [CrossRef]
- Navarese, E.P.; Robinson, J.G.; Kowalewski, M.; Kołodziejczak, M.; Andreotti, F.; Bliden, K. Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis. JAMA 2018, 319, 1566–1579. [Google Scholar] [CrossRef]
- Cholesterol Treatment Trialists’ (CTT) Collaboration; Fulcher, J.; Oçonnel, R.; Voysey, M.; Emberson, J.; Blackwell, L.; Mihaylove, B.; Simes, J.; Collins, R.; Kirby, A.; et al. Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet 2015, 385, 1397–1405. [Google Scholar]
- Joint Committee of the Chinese Guidelines for Lipid Management. Chinese guidelines for lipid management (2023). Chin. J. Cardiol. 2023, 51, 221–255. [Google Scholar]
- National Health Commission of China; Department of Chronic Disease and Prevention Bureau. Report on the Nutritional and Chronic Disease Status of Chinese Residents (2020); People’s Medical Publishing House: Beijing, China, 2021.
- Yu, D.; Zhao, L.; Zhang, J.; Yang, Z.; Yang, L.; Huang, J. China Nutrition and Health Surveys (1982–2017). China CDC Wkly. 2021, 3, 193–195. [Google Scholar] [CrossRef] [PubMed]
- Chinese Nutrition Society. Dietary Guidelines for Chinese Residents (2022); People’s Medical Publishing House: Beijing, China, 2022. [Google Scholar]
- WHO. International Guide for Monitoring Alcohol Consumption and Related Harm; WHO: Geneva, Switzerland, 2002.
- WS/T 428–2013; National Health Commission of the People’s Republic of China. Adult Weight Judgment. Standards Press of China: Beijing, China, 2013.
- Bull, F.C.; Al-Ansari, S.S.; Biddle, S.; Borodulin, K.; Buman, M.P.; Cardon, G. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br. J. Sports Med. 2020, 54, 1451–1462. [Google Scholar] [CrossRef]
- The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC); European Atherosclerosis Society (EAS). 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur. Heart J. 2019, 41, 111–188. [Google Scholar]
- Frohlich, J.J. Effects of alcohol on plasma lipoprotein metabolism. Clin. Chim. Acta 1996, 246, 39–49. [Google Scholar] [CrossRef] [PubMed]
- Chen, Y.; Du, J.; Zhou, N.; Song, Y.; Wang, W.; Hong, X. Prevalence, awareness, treatment and control of dyslipidaemia and their determinants: Results from a population-based survey of 60,283 residents in eastern China. BMJ Open 2023, 13, e075860. [Google Scholar] [CrossRef] [PubMed]
- Hu, C.H.; Zhang, M.; Li, C.; Zhao, Z.P.; Zhang, X.; Huang, Z.J. Study on the relationship between drinking behavior and dyslipidemia among Chinese adults. Dis. Surveill. 2020, 35, 697–705. [Google Scholar]
- Kim, S.K.; Hong, S.H.; Chung, J.H.; Cho, K.B. Association Between Alcohol Consumption and Metabolic Syndrome in a Community-Based Cohort of Korean Adults. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2017, 23, 2104–2110. [Google Scholar] [CrossRef]
- Oh, S.S.; Kim, W.; Han, K.T.; Park, E.C.; Jang, S.I. Alcohol consumption frequency or alcohol intake per drinking session: Which has a larger impact on the metabolic syndrome and its components? Alcohol 2018, 71, 15–23. [Google Scholar] [CrossRef]
- Barrio-Lopez, M.T.; Bes-Rastrollo, M.; Sayon-Orea, C.; Garcia-Lopez, M.; Fernandez-Montero, A.; Gea, A.; Martinez-Gonzalez, M.A. Different types of alcoholic beverages and incidence of metabolic syndrome and its components in a Mediterranean cohort. Clin. Nutr. 2013, 32, 797–804. [Google Scholar] [CrossRef]
- Hansel, B.; Thomas, F.; Pannier, B.; Bean, K.; Kontush, A.; Chapman, M.J. Relationship between alcohol intake, health and social status and cardiovascular risk factors in the Urban Paris-Ile-de-France Cohort: Is the cardioprotective action of alcohol a myth? Eur. J. Clin. Nutr. 2010, 64, 561–568. [Google Scholar] [CrossRef]
- Shen, Z.; Munker, S.; Wang, C.; Xu, L.; Ye, H.; Chen, H.; Xu, G.; Zhang, H.; Chen, L.; Yu, C.; et al. Association between alcohol intake, overweight, and serum lipid levels and the risk analysis associated with the development of dyslipidemia. J. Clin. Lipidol. 2014, 8, 273–278. [Google Scholar] [CrossRef]
- Klop, B.; do Rego, A.T.; Cabezas, M.C. Alcohol and plasma triglycerides. Curr. Opin. Lipidol. 2013, 24, 321–326. [Google Scholar] [CrossRef]
- Capurso, N.A.; Petrakis, I. Dyslipidemia associated with heavy alcohol use. Am. J. Addict. 2016, 25, 188–190. [Google Scholar] [CrossRef] [PubMed]
- Park, H.; Kim, K. Alcohol, and alcoholism, Association of alcohol consumption with lipid profile in hypertensive men. Alcohol Alcohol. 2012, 47, 282–287. [Google Scholar] [CrossRef] [PubMed]
- Alcohol, I.W.J. Associations between heavy alcohol drinking and lipid-related indices in middle-aged men. Alcohol 2013, 47, 637–642. [Google Scholar]
- Li, X.X.; Zhao, Y.; Huang, L.X.; Xu, H.X.; Liu, X.Y.; Yang, J.J. Effects of smoking and alcohol consumption on lipid profile in male adults in northwest rural China. Public Health 2018, 157, 7–13. [Google Scholar] [CrossRef]
- Suliga, E.; Kozieł, D.; Ciesla, E.; Rebak, D.; Głuszek-Osuch, M.; Głuszek, S. Consumption of Alcoholic Beverages and the Prevalence of Metabolic Syndrome and Its Components. Nutrients 2019, 11, 2764. [Google Scholar] [CrossRef]
- Park, S.; Kang, S. Nutrition, and Dietetics, Alcohol, Carbohydrate, and Calcium Intakes and Smoking Interactions with APOA5 rs662799 and rs2266788 were Associated with Elevated Plasma Triglyceride Concentrations in a Cross-Sectional Study of Korean Adults. J. Acad. Nutr. Diet. 2020, 120, 1318–1329.e1. [Google Scholar] [CrossRef]
- Luo, F.; Huang, W.-Y.; Guo, Y.; Ruan, G.-Y.; Peng, R.; Li, X.-P. 17β-estradiol lowers triglycerides in adipocytes via estrogen receptor α and it may be attenuated by inflammation. Lipids Health Dis. 2017, 16, 182. [Google Scholar] [CrossRef] [PubMed]
- Xu, X.; Fang, H.; Ji, Q.; Deng, X.; Dai, T.; Li, J.; Xiong, D.; Xie, H.; Liu, X. Changes in alcohol consumption amoung Chinese adults from 2002 to 2015. J. Hyg. Res. 2025, 54, 201–207. [Google Scholar]
- Arranz, S.; Valderas-Martinez, P.; Chiva-Blanch, G.; Casas, R.; Urpi-Sarda, M.; Lamuela-Raventos, R.M.; Estruch, R. Cardioprotective effects of cocoa: Clinical evidence from randomized clinical intervention trials in humans. Mol. Nutr. Food Res. 2013, 57, 936–947. [Google Scholar] [CrossRef]
- Longnecker, M.P.; Tseng, M. Alcohol, hormones, and postmenopausal women. Alcohol Health Res. World 1998, 22, 185–189. [Google Scholar]
- Rimm, E.B.; Williams, P.; Fosher, K.; Criqui, M.; Stampfer, M.J. Moderate alcohol intake and lower risk of coronary heart disease: Meta-analysis of effects on lipids and haemostatic factors. BMJ 1999, 319, 1523–1528. [Google Scholar] [CrossRef]
- Vatsalya, V.; Bin Liaquat, H.; Ghosh, K.; Mokshagundam, S.P.; McClain, C.J. A Review on the Sex Differences in Organ and System Pathology with Alcohol Drinking. Curr. Drug Abus. Rev. 2016, 9, 87–92. [Google Scholar] [CrossRef] [PubMed]
- Institute of Medicine, Committee on Health. Health and Behavior: The Interplay of Biological, Behavioral, and Societal Influences; Institute of Medicine, Committee on Health: Washington, DC, USA, 2001. [Google Scholar]
- Erol, A.; Karpyak, V.M. Sex and gender-related differences in alcohol use and its consequences: Contemporary knowledge and future research considerations. Drug Alcohol Depend. 2015, 156, 1–13. [Google Scholar] [CrossRef]
- Huang, S.; Li, J.; Shearer, G.C.; Lichtenstein, A.H.; Zheng, X.; Wu, Y.; Jin, C.; Wu, S.; Gao, X. Longitudinal study of alcohol consumption and HDL concentrations: A community-based study. Am. J. Clin. Nutr. 2017, 105, 905–912. [Google Scholar] [CrossRef]
- Hannuksela, M.L.; Rämet, M.E.; Nissinen, A.E.; Liisanantti, M.K.; Savolainen, M.J. Effects of ethanol on lipids and atherosclerosis. Pathophysiology 2004, 10, 93–103. [Google Scholar] [CrossRef]
- Kwon, Y.-J.; Kim, S.E.; Park, B.-J.; Bae, J.-W.; Kang, H.-T. High-risk drinking is associated with dyslipidemia in a different way, based on the 2010–2012 KNHANES. Clin. Chim. Acta 2016, 456, 170–175. [Google Scholar] [CrossRef]
- De Oliveira e Silva, E.R.; Foster, D.; Harper, M.M.; Seidman, C.E.; Smith, J.D.; Breslow, J.L.; Brinton, E.A. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation 2000, 102, 2347–2352. [Google Scholar] [CrossRef]
- Beulens, J.W.J.; Sierksma, A.; van Tol, A.; Fournier, N.; van Gent, T.; Paul, J.-L.; Hendriks, H.F.J. Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1. J. Lipid Res. 2004, 45, 1716–1723. [Google Scholar] [CrossRef] [PubMed]
- Muth, N.D.; Laughlin, G.A.; von Mühlen, D.; Smith, S.C.; Barrett-Connor, E. High-density lipoprotein subclasses are a potential intermediary between alcohol intake and reduced risk of cardiovascular disease: The Rancho Bernardo Study. Br. J. Nutr. 2010, 104, 1034–1042. [Google Scholar] [CrossRef] [PubMed]
- Kontush, A.; Chapman, M.J. Antiatherogenic small, dense HDL—Guardian angel of the arterial wall? Nat. Clin. Pract. Cardiovasc. Med. 2006, 3, 144–153. [Google Scholar] [CrossRef]
- Cho, K.-H.; Nam, H.-S.; Kang, D.-J.; Park, M.-H.; Kim, J.-H. Long-Term Alcohol Consumption Caused a Significant Decrease in Serum High-Density Lipoprotein (HDL)-Cholesterol and Apolipoprotein A-I with the Atherogenic Changes of HDL in Middle-Aged Korean Women. Int. J. Mol. Sci. 2022, 23, 8623. [Google Scholar] [CrossRef] [PubMed]
- Marmillot, P.; Munoz, J.; Patel, S.; Garige, M.; Rosse, R.B.; Lakshman, M.R. Long-term ethanol consumption impairs reverse cholesterol transport function of high-density lipoproteins by depleting high-density lipoprotein sphingomyelin both in rats and in humans. Metabolism 2007, 56, 947–953. [Google Scholar] [CrossRef]
- Kechagias, S.; Zanjani, S.; Gjellan, S.; Leinhard, O.D.; Kihlberg, J.; Smedby, Ö.; Johansson, L.; Kullberg, J.; Ahlström, H.; Lindström, T.; et al. Effects of moderate red wine consumption on liver fat and blood lipids: A prospective randomized study. Ann. Med. 2011, 43, 545–554. [Google Scholar] [CrossRef] [PubMed]
- Chiva-Blanch, G.; Urpi-Sarda, M.; Ros, E.; Valderas-Martinez, P.; Casas, R.; Arranz, S.; Guillén, M.; Lamuela-Raventós, R.M.; Llorach, R.; Andres-Lacueva, C.; et al. Effects of red wine polyphenols and alcohol on glucose metabolism and the lipid profile: A randomized clinical trial. Clin. Nutr. 2013, 32, 200–206. [Google Scholar] [CrossRef] [PubMed]
Characteristics | Male | Female | Total | |||
---|---|---|---|---|---|---|
n | Percentage (%) | n | Percentage (%) | n | Percentage (%) | |
Age group (Years) | ||||||
18–44 | 5735 | 23.9 | 7487 | 26.3 | 13,222 | 25.2 |
45–59 | 8666 | 36.1 | 10,944 | 38.5 | 19,610 | 37.4 |
60–69 | 6262 | 26.1 | 6859 | 24.1 | 13,121 | 25.0 |
70–79 | 2737 | 11.4 | 2573 | 9.1 | 5310 | 10.1 |
≥80 | 628 | 2.6 | 580 | 2.0 | 1208 | 2.3 |
Residential area | ||||||
Urban | 9460 | 39.4 | 11,538 | 40.6 | 20,998 | 40.0 |
Rural | 14,568 | 60.6 | 16,905 | 59.4 | 31,473 | 60.0 |
Educational level * | ||||||
NS | 5216 | 21.7 | 11,625 | 40.9 | 16,841 | 32.1 |
PS | 5532 | 23.0 | 5571 | 19.6 | 11,103 | 21.2 |
JS | 8092 | 33.7 | 6923 | 24.3 | 15,015 | 28.6 |
HS | 3500 | 14.6 | 2655 | 9.3 | 6155 | 11.7 |
TS | 1004 | 4.2 | 1051 | 3.7 | 2055 | 3.9 |
C or above | 684 | 2.9 | 618 | 2.2 | 1302 | 2.5 |
Smoking status | ||||||
Current | 12,538 | 52.2 | 829 | 2.9 | 13,367 | 25.5 |
Former | 3555 | 14.8 | 223 | 0.8 | 3778 | 7.2 |
Never | 7935 | 33.0 | 27,391 | 96.3 | 35,326 | 67.3 |
Physical activity status | ||||||
Insufficient | 4838 | 20.1 | 4616 | 16.2 | 9454 | 18.0 |
Sufficient | 19,190 | 79.9 | 23,827 | 83.8 | 43,017 | 82.0 |
Weight status | ||||||
Obesity | 3226 | 13.4 | 4326 | 15.2 | 7552 | 14.4 |
Overweight | 8624 | 35.9 | 9865 | 34.7 | 18,489 | 35.2 |
Normal | 11,316 | 47.1 | 13,099 | 46.1 | 24,415 | 46.5 |
Underweight | 862 | 3.6 | 1153 | 4.1 | 2015 | 3.8 |
Daily average intake of rice and wheat flour staple food (g) | ||||||
<150 | 3135 | 13.1 | 6410 | 22.5 | 9545 | 18.2 |
150–249 | 5933 | 24.7 | 8895 | 31.3 | 14,828 | 28.3 |
250–400 | 7975 | 33.2 | 8484 | 29.8 | 16,459 | 31.4 |
>400 | 6985 | 29.1 | 4654 | 16.4 | 11,639 | 22.2 |
Daily average intake of red meat (g) | ||||||
0 | 513 | 2.1 | 1171 | 4.1 | 1684 | 3.2 |
0–39 | 10,022 | 41.7 | 14,832 | 52.2 | 24,854 | 47.4 |
40–75 | 5443 | 22.7 | 6025 | 21.2 | 11,468 | 21.9 |
>75 | 8050 | 33.5 | 6415 | 22.6 | 14,465 | 27.6 |
Daily fresh vegetable intake (g) | ||||||
<120 | 5421 | 22.6 | 6933 | 24.4 | 12,354 | 23.5 |
120–239 | 5904 | 24.6 | 7408 | 26.1 | 13,312 | 25.4 |
240–299 | 1047 | 4.4 | 1247 | 4.4 | 2294 | 4.4 |
300–500 | 8509 | 35.4 | 9639 | 33.9 | 18,148 | 34.6 |
>500 | 3147 | 13.1 | 3216 | 11.3 | 6363 | 12.1 |
Daily fresh fruit intake (g) | ||||||
<25 | 8742 | 36.4 | 8843 | 31.1 | 17,585 | 33.5 |
25–99 | 7465 | 31.1 | 8391 | 29.5 | 15,856 | 30.2 |
100–199 | 4268 | 17.8 | 5982 | 21.0 | 10,250 | 19.5 |
200–350 | 2836 | 11.8 | 4038 | 14.2 | 6874 | 13.1 |
>350 | 717 | 3.0 | 1189 | 4.2 | 1906 | 3.6 |
Prevalence of dyslipidemia | ||||||
Hyperlipidemia | 8969 | 37.3 | 8595 | 30.2 | 17,564 | 33.5 |
Hypercholesterolemia | 1770 | 7.4 | 26.6 | 9.2 | 4376 | 8.3 |
Hypertriglyceridemia | 4142 | 7.9 | 3833 | 7.3 | 7975 | 15.2 |
Low HDL-C | 5578 | 10.6 | 4051 | 7.7 | 9629 | 18.4 |
High LDL-C | 2186 | 4.2 | 3072 | 5.9 | 5253 | 10.0 |
Total | 24,028 | 46 | 28,443 | 54 | 52,471 | 100 |
Characteristics | Male | Female | ||
---|---|---|---|---|
n | Percentage (%) | n | Percentage (%) | |
Alcohol Consumption (China Classification) | ||||
Never | 10,205 | 42.5 | 23,184 | 81.5 |
Moderate | 7309 | 30.4 | 4751 | 16.7 |
Excessive | 6514 | 27.1 | 508 | 1.8 |
Alcohol Consumption (WHO Classification) | ||||
Never | 10,205 | 42.5 | 23,184 | 81.5 |
Low risk | 10,101 | 42.0 | 4872 | 17.1 |
Medium risk | 1351 | 5.6 | 218 | 0.8 |
High risk | 2371 | 9.9 | 169 | 0.6 |
Alcohol Consumption Frequency (Times/Week) | ||||
Never | 10,205 | 42.5 | 23,184 | 81.5 |
<1 | 4506 | 18.8 | 3614 | 12.7 |
1–3 | 7402 | 30.8 | 1447 | 5.1 |
4–6 | 1605 | 6.7 | 175 | 0.6 |
≥7 | 310 | 1.3 | 23 | 0.1 |
Total | 24,028 | 45.8 | 28,443 | 54.2 |
Characteristics | TC M (P25, P75) | TG M (P25, P75) | HDL-C M (P25, P75) | LDL-C M (P25, P75) | |
---|---|---|---|---|---|
Male | Alcohol Consumption (China Classification) | ||||
Never | 4.61 (4.02, 5.26) a | 1.18 (0.83, 1.77) a | 1.17 (0.98, 1.39) a | 2.89 (2.35, 3.46) | |
Moderate | 4.67 (4.09, 5.29) b | 1.26 (0.87, 1.92) b | 1.17 (0.99, 1.40) a | 2.92 (2.40, 3.45) | |
Excessive | 4.84 (4.27, 5.54) c | 1.25 (0.83, 2.01) b | 1.33 (1.09, 1.61) b | 2.90 (2.37, 3.44) | |
χ2 | 242.324 | 55.213 | 901.271 | 5.896 | |
p | <0.0001 | <0.0001 | <0.0001 | 0.05 | |
Alcohol Consumption (WHO Classification) | |||||
Never | 4.61 (4.02, 5.26) a | 1.18 (0.83, 1.77) a | 1.17 (0.98, 1.39) a | 2.89 (2.35, 3.46) | |
Low risk | 4.69 (4.13, 5.31) b | 1.26 (0.86, 1.93) b | 1.20 (1.01, 1.43) b | 2.92 (2.40, 3.45) a | |
Medium risk | 4.83 (4.23, 5.42) c | 1.23 (0.81, 1.97) | 1.32 (1.10, 1.58) c | 2.88 (2.37, 3.43) | |
High risk | 4.95 (4.35, 5.56) d | 1.26 (0.82, 2.08) b | 1.41 (1.15, 1.71) d | 2.88 (2.33, 3.44) b | |
χ2 | 252.428 | 56.575 | 929.569 | 12.916 | |
p | <0.0001 | <0.0001 | <0.0001 | 0.0048 | |
Alcohol Consumption Frequency (Times/Week) | |||||
Never | 4.61 (4.02, 5.26) a | 1.18 (0.83, 1.77) a | 1.17 (0.98, 1.39) a | 2.89 (2.35, 3.46) | |
<1 | 4.64 (4.07, 5.26) a | 1.28 (0.88, 1.94) b | 1.15 (0.98, 1.37) a | 2.91 (2.42, 3.45) | |
1–3 | 4.80 (4.23, 5.41) b | 1.22 (0.82, 1.93) c | 1.29 (1.07, 1.56) b | 2.91 (2.37, 3.45) | |
4–6 | 4.81 (4.18, 5.41) b | 1.29 (0.85, 2.08) b | 1.28 (1.06, 1.55) b | 2.89 (2.35, 3.45) | |
≥7 | 4.90 (4.31, 5.42) b | 1.36 (0.90, 2.16) b | 1.31 (1.09, 1.51) b | 2.98 (2.47, 3.45) | |
χ2 | 210.560 | 72.881 | 792.797 | 5.032 | |
p | <0.0001 | <0.0001 | <0.0001 | 0.28 | |
Female | Alcohol Consumption (China Classification) | ||||
Never | 4.80 (4.18, 5.48) a | 1.21 (0.83, 1.78) a | 1.29 (1.09, 1.51) a | 2.96 (2.42, 3.55) a | |
Moderate | 4.72 (4.11, 5.40) b | 1.12 (0.79, 1.63) b | 1.31 (1.12, 1.52) b | 2.89 (2.35, 3.49) b | |
Excessive | 5.07 (4.47, 5.66) c | 1.23 (0.84, 1.72) a | 1.45 (1.21, 1.68) c | 3.05 (2.48, 3.58) a | |
χ2 | 56.591 | 59.999 | 113.545 | 30.132 | |
p | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
Alcohol Consumption (WHO Classification) | |||||
Never | 4.80 (4.18, 5.48) a | 1.21 (0.83, 1.78) a | 1.29 (1.09, 1.51) a | 2.96 (2.42, 3.55) a | |
Low risk | 4.72 (4.12, 5.41) b | 1.12 (0.79, 1.64) b | 1.31 (1.12, 1.53) b | 2.89 (2.36, 3.49) b | |
Medium risk | 5.13 (4.51, 5.63) c | 1.19 (0.83, 1.65) | 1.46 (1.23, 1.66) c | 3.06 (2.43, 3.61) | |
High risk | 5.08 (4.48, 5.65) c | 1.17 (0.76, 1.85) | 1.51 (1.26, 1.75) c | 2.94 (2.43, 3.46) | |
χ2 | 47.366 | 55.481 | 127.764 | 24.165 | |
p | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
Alcohol Consumption Frequency (Times/Week) | |||||
Never | 4.80 (4.18, 5.48) a | 1.21 (0.83, 1.78) a | 1.29 (1.09, 1.51) a | 2.96 (2.42, 3.55) a | |
<1 | 4.69 (4.08, 5.37) b | 1.11 (0.79, 1.63) b | 1.30 (1.11, 1.51) a | 2.87 (2.33, 3.47) b | |
≥1 | 4.90 (4.26, 5.53) c | 1.16 (0.80, 1.66) b | 1.38 (1.17, 1.61) b | 2.98 (2.43, 3.54) a | |
χ2 | 54.084 | 56.060 | 117.476 | 32.914 | |
p | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
Characteristics | High TC | High TG | Low HDL-C | High LDL-C | ||||
---|---|---|---|---|---|---|---|---|
OR (95%CI) | aOR (95%CI) | OR (95%CI) | aOR (95%CI) | OR (95%CI) | aOR (95%CI) | OR (95%CI) | aOR (95%CI) | |
Alcohol Consumption (China Classification) | ||||||||
Never | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Moderate | 1.00 (0.89–1.13) | 1.00 (0.88–1.13) | 1.22 (1.12–1.32) * | 1.05 (0.97–1.15) | 0.93 (0.86–0.99) * | 0.82 (0.77–0.89) * | 0.94 (0.85–1.05) | 0.94 (0.84–1.04) |
Excessive | 1.50 (1.34–1.68) * | 1.39 (1.24–1.57) * | 1.49 (1.38–1.62) * | 1.35 (1.24–1.47) * | 0.51 (0.47–0.55) * | 0.48 (0.44–0.52) * | 0.91 (0.82–1.02) | 0.86 (0.77–0.97) * |
χ2 | 59.966 | 38.121 | 94.423 | 52.729 | 294.159 | 301.349 | 2.943 | 6.4 |
p | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.23 | 0.0408 |
Alcohol Consumption (WHO Classification) | ||||||||
Never | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Low risk | 1.08 (0.97–1.21) | 1.06 (0.95–1.19) | 1.27 (1.18–1.38) * | 1.10 (1.02–1.19) * | 0.84 (0.79–0.90) * | 0.76 (0.71–0.81) * | 0.95 (0.86–1.04) | 0.93 (0.85–1.03) |
Medium risk | 1.33 (1.08–1.63) * | 1.24 (1.01–1.53) * | 1.41 (1.22–1.63) * | 1.29 (1.11–1.50) * | 0.45 (0.38–0.52) * | 0.42 (0.36–0.50) * | 0.84 (0.69–1.04) | 0.80 (0.65–0.99) * |
High risk | 1.85 (1.59–2.14) * | 1.67 (1.43–1.95) * | 1.64 (1.47–1.84) * | 1.52 (1.35–1.71) * | 0.38 (0.34–0.44) * | 0.38 (0.33–0.43) * | 0.9 (0.76–1.05) | 0.83 (0.70–0.97) * |
χ2 | 70.722 | 46.091 | 93.641 | 53.746 | 281.063 | 288.675 | 4.161 | 8.257 |
p | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.2446 | 0.041 |
Alcohol Consumption Frequency (Times/Week) | ||||||||
Never | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
<1 | 0.95 (0.82–1.10) | 0.95 (0.82–1.10) | 1.24 (1.13–1.36) * | 1.06 (0.96–1.17) | 1.02 (0.94–1.10) | 0.90 (0.83–0.97) * | 0.93 (0.82–1.05) | 0.93 (0.82–1.05) |
1–3 | 1.34 (1.20–1.51) * | 1.27 (1.13–1.43) * | 1.34 (1.24–1.45) * | 1.22 (1.12–1.33) * | 0.58 (0.54–0.63) * | 0.55 (0.51–0.59) * | 0.92 (0.83–1.02) | 0.89 (0.79–0.99) * |
4–6 | 1.44 (1.19–1.73) * | 1.33 (1.10–1.61) * | 1.62 (1.42–1.84) * | 1.36 (1.19–1.55) * | 0.62 (0.54–0.71) * | 0.56 (0.49–0.64) * | 0.92 (0.76–1.11) | 0.87 (0.72–1.05) |
≥7 | 1.76 (1.22–2.53) * | 1.65 (1.14–2.38) * | 1.64 (1.25–2.16) * | 1.38 (1.05–1.83) * | 0.48 (0.35–0.66) * | 0.42 (0.31–0.58) * | 1.22 (0.86–1.75) | 1.16 (0.81–1.66) |
χ2 | 47.971 | 31.406 | 87.338 | 35.667 | 270.478 | 281.48 | 5.012 | 7.143 |
p | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.2861 | 0.1285 |
Characteristics | High TC | High TG | Low HDL-C | High LDL-C | ||||
---|---|---|---|---|---|---|---|---|
OR (95%CI) | aOR (95%CI) | OR (95%CI) | aOR (95%CI) | OR (95%CI) | aOR (95%CI) | OR (95%CI) | aOR (95%CI) | |
Alcohol Consumption (China Classification) | ||||||||
Never | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Moderate | 0.82 (0.73–0.92) * | 0.94 (0.83–1.05) | 0.79 (0.72–0.87) * | 0.85 (0.77–0.94) * | 0.84 (0.77–0.92) * | 0.84 (0.77–0.93) * | 0.80 (0.72–0.89) * | 0.90 (0.81–1.01) |
Excessive | 1.20 (0.90–1.58) | 1.05 (0.79–1.39) | 0.94 (0.73–1.22) | 0.89 (0.68–1.15) | 0.47 (0.34–0.65) * | 0.47 (0.34–0.66) * | 1.13 (0.87–1.48) | 1.00 (0.76–1.32) |
χ2 | 13.6989 | 1.3629 | 22.3474 | 10.4013 | 32.2812 | 30.8687 | 17.6285 | 3.3331 |
p | 0.0011 | 0.5059 | <0.0001 | 0.0055 | <0.0001 | <0.0001 | 0.0001 | 0.1889 |
Alcohol Consumption (WHO Classification) | ||||||||
Never | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Low risk | 0.83 (0.74–0.92) * | 0.94 (0.83–1.05) | 0.80 (0.72–0.88) * | 0.86 (0.78–0.94) * | 0.84 (0.76–0.92) * | 0.84 (0.76–0.92) * | 0.82 (0.74–0.91) * | 0.92 (0.82–1.02) |
Medium risk | 1.19 (0.78–1.83) | 1.09 (0.70–1.68) | 0.73 (0.47–1.13) | 0.7 (0.45–1.09) | 0.52 (0.32–0.85) * | 0.52 (0.32–0.84) * | 0.99 (0.65–1.52) | 0.90 (0.58–1.39) |
High risk | 1.30 (0.81–2.07) | 1.07 (0.67–1.72) | 1.18 (0.78–1.78) | 1.09 (0.72–1.65) | 0.25 (0.12–0.53) * | 0.26 (0.12–0.55) * | 1.01 (0.63–1.64) | 0.85 (0.53–1.39) |
χ2 | 13.3958 | 1.5127 | 24.1004 | 12.2052 | 33.266 | 31.7914 | 13.7376 | 2.937 |
p | 0.0039 | 0.6793 | <0.0001 | 0.0067 | <0.0001 | <0.0001 | 0.0033 | 0.4014 |
Alcohol Consumption Frequency (Times/Week) | ||||||||
Never | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
<1 | 0.78 (0.68–0.89) * | 0.94 (0.82–1.07) | 0.82 (0.74–0.92) * | 0.92 (0.82–1.02) | 0.90 (0.82–1.00) | 0.91 (0.82–1.01) | 0.77 (0.68–0.87) * | 0.91 (0.81–1.04) |
≥1 | 1.03 (0.87–1.21) | 0.97 (0.82–1.16) | 0.77 (0.65–0.90) * | 0.74 (0.63–0.87) * | 0.59 (0.50–0.70) * | 0.59 (0.50–0.70) * | 0.97 (0.83–1.14) | 0.91(0.78–1.08) |
χ2 | 14.2258 | 0.9825 | 22.0628 | 14.6089 | 38.9696 | 38.3608 | 17.2455 | 2.8535 |
p | 0.002 | 0.6119 | <0.0001 | 0.0007 | <0.0001 | <0.0001 | 0.0006 | 0.2401 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Xu, X.; Li, S.; Wang, H.; Guo, Q.; Fang, H.; Ju, L.; Cheng, X.; Gong, W.; Wei, X.; Du, W.; et al. Associations Between Alcohol Consumption Patterns and Dyslipidemia Among Chinese Adults Aged 18 and Above: China Nutrition and Health Surveillance (2015–2017). Nutrients 2025, 17, 3112. https://doi.org/10.3390/nu17193112
Xu X, Li S, Wang H, Guo Q, Fang H, Ju L, Cheng X, Gong W, Wei X, Du W, et al. Associations Between Alcohol Consumption Patterns and Dyslipidemia Among Chinese Adults Aged 18 and Above: China Nutrition and Health Surveillance (2015–2017). Nutrients. 2025; 17(19):3112. https://doi.org/10.3390/nu17193112
Chicago/Turabian StyleXu, Xiaoli, Shujuan Li, Huijun Wang, Qiya Guo, Hongyun Fang, Lahong Ju, Xue Cheng, Weiyi Gong, Xiaoqi Wei, Wenwen Du, and et al. 2025. "Associations Between Alcohol Consumption Patterns and Dyslipidemia Among Chinese Adults Aged 18 and Above: China Nutrition and Health Surveillance (2015–2017)" Nutrients 17, no. 19: 3112. https://doi.org/10.3390/nu17193112
APA StyleXu, X., Li, S., Wang, H., Guo, Q., Fang, H., Ju, L., Cheng, X., Gong, W., Wei, X., Du, W., Zhang, J., & Liu, A. (2025). Associations Between Alcohol Consumption Patterns and Dyslipidemia Among Chinese Adults Aged 18 and Above: China Nutrition and Health Surveillance (2015–2017). Nutrients, 17(19), 3112. https://doi.org/10.3390/nu17193112